XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.25.3

STOCKHOLDERS’ EQUITY (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Equity [Abstract] |
Schedule of black scholes option pricing model using assumptions |
Schedule of black scholes option pricing model using assumptions |  |  |
|  | At September 30, 2025 |
Grant date share price |  |  | $7.11 - $7.26 |
Grant date exercise price |  |  | $5.64 - $6.17 |
Expected term |  |  | 0.25 years - 0.5 years |
Expected volatility |  |  | 69.5% - 105.3 | %
Risk-free rate |  |  | 4.02% - 4.32 | %
Expected dividend rate |  |  | 0 | %
Schedule of stock-based compensation |
Schedule of stock-based compensation |  |  |
|  | For the Nine Months ended September 30, 2025 |
Cash payment received from employee withholding |  | $ | 173,102 |
Cash from employee withholdings used to purchase shares under ESPP |  |  | (114,724 | )
Accrued employee withholdings at September 30, 2025 |  | $ | 58,378 |
|  | For the Nine Months ended September 30, 2025 |
Cash from employee withholdings used to purchase ESPP shares |  | $ | 114,724 |
Stock based compensation expense |  |  | 88,986 |
Total increase to equity for nine months ended September 30, 2025 |  | $ | 203,710 |
|  | For the Nine Months ended September 30, 2024 |
Cash from employee withholdings used to purchase ESPP shares |  | $ | 123,359 |
Stock based compensation expense |  |  | 54,833 |
Total increase to equity for nine months ended September 30, 2024 |  | $ | 178,192 |
Schedule of options |
Schedule of options |  |  |  |  |  |  |  |  |  |  |  |  |
|  |  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |  |  |  | 1,387,775 |  |  | $ | 5.23 |  |  |  | 3.0 |  |  | $ | — |
Granted |  |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Forfeited |  |  |  | (781,323 | ) |  | $ | 5.17 |  |  |  | — |  |  | $ | — |
Outstanding at December 31, 2024 |  |  |  | 606,452 |  |  | $ | 5.29 |  |  |  | 2.0 |  |  | $ | 514,394 |
Exercisable at December 31, 2024 |  |  |  | 442,445 |  |  | $ | 5.50 |  |  |  | 1.6 |  |  | $ | 296,145 |
Outstanding at December 31, 2024 |  |  |  | 606,452 |  |  | $ | 5.29 |  |  |  | 2.0 |  |  | $ | 514,394 |
Granted |  |  |  | 20,000 |  |  | $ | 5.64 |  |  |  | 4.5 |  |  | $ | 34,400 |
Exercised/Forfeited/Expired |  |  |  | (141,327 | ) |  | $ | 5.31 |  |  |  | — |  |  | $ | — |
Outstanding at September 30, 2025 |  |  |  | 485,125 |  |  | $ | 5.30 |  |  |  | 1.9 |  |  | $ | 997,153 |
Exercisable at September 30, 2025 |  |  |  | 386,456 |  |  | $ | 5.51 |  |  |  | 1.6 |  |  | $ | 715,732 |
Schedule of assumptions in determining the fair value of the warrants |
Schedule of assumptions in determining the fair value of the warrants |  |  |  |  |  |
|  |  | Upon Grant |
|  |  | Titan |  |  |  | Titan |
Date of Grant |  |  | August 1, 2025 |  |  |  | September 2, 2025 |
Stock Price |  | $ | 6.57 |  |  | $ | 6.25 |
Exercise Price |  | $ | 7.20 |  |  | $ | 7.20 |
Expected Remaining Term (Years) |  |  | 5.00 |  |  |  | 5.00 |
Historical Volatility |  |  | 73 | % |  |  | 55 | %
Expected Volatility |  |  | 36 | % |  |  | 33 | %
Dividend Yield |  |  | 0 | % |  |  | 0 | %
Annual Rate of Quarterly Dividends |  | $ | 0.000 |  |  | $ | 0.000 |
Discount Rate - Bond Equivalent Yield |  |  | 3.770 | % |  |  | 3.740 | %
Schedule of warrants |
Schedule of warrants |  |  |  |  |  |  |  |  |  |  |  |
|  | Number of Warrants |  |  | Weighted Average Exercise Price |  |  | Weighted Average Remaining Contractual Term (Years) |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2023 |  |  | 44,644 |  |  | $ | 7.70 |  |  |  | 0.7 |  |  | $ | — |
Warrants expired, forfeited, cancelled or exercised |  |  | (344,644 | ) |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants issued |  |  | 300,000 |  |  | $ | 3.00 |  |  |  | — |  |  | $ | — |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Exercisable at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Outstanding at December 31, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Warrants issued |  |  | 375,276 |  |  | $ | 7.20 |  |  |  | 5.0 |  |  | $ | — |
Warrants expired, forfeited, cancelled or exercised |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | — |
Outstanding at September 30, 2025 |  |  | 375,276 |  |  | $ | 7.20 |  |  |  | 4.8 |  |  | $ | 60,044 |
Exercisable at September 30, 2025 |  |  | 375,276 |  |  | $ | 7.20 |  |  |  | 4.8 |  |  | $ | 60,044 |
Schedule of restricted stock unit |
Schedule of restricted stock unit |  |  |  |  |  |
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value Per Share |
Unvested at December 31, 2023 |  | — |  |  | $ | — |
Restricted stock forfeited |  | — |  |  | $ | — |
Restricted stock granted |  | — |  |  | $ | — |
Unvested at December 31, 2024 |  | — |  |  | $ | — |
Vested at December 31, 2024 |  | — |  |  | $ | — |
Unvested at December 31, 2024 |  |  | — |  |  | $ | — |
Restricted stock granted |  |  | 2,146,898 |  |  | $ | 6.13 |
Restricted stock forfeited |  |  | (112,500 | ) |  | $ | 5.98 |
Restricted stock vested |  |  | (20,000 | ) |  | $ | 5.22 |
Unvested at September 30, 2025 |  |  | 2,014,398 |  |  | $ | 6.14 |
Vested at September 30, 2025 |  |  | 20,000 |  |  | $ | 5.22 |

X
- References No definition available. + Details
Name: | duot_AssumptionsInDeterminingTheFairValueOfTheWarrantsTableTextBlock
Namespace Prefix: | duot_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of employee stock purchase plan activity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 50 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718-50/tableOfContent Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration